Clinical Trial

MRA Diameter as a Predictor for LLN Metastasis in Rectal Cancer.

Completed
View on ClinicalTrials.gov →
Summary
This study aims to identify risk factors-including clinical and imaging indicators such as middle rectal artery (MRA) diameter-that may be associated with lateral lymph node metastasis (LLNM) in rectal cancer located below the peritoneal reflection, and to construct a corresponding predictive model.The main questions it aims to answer are: What factors are associated with clinically suspected lateral lymph node metastasis in rectal cancer below the peritoneal reflection? Can an effective predictive model be constructed based on these factors? Participants' clinical information has been collected for statistical analysis.
Trial Details
NCT Number NCT07419516
Lead Sponsor First Affiliated Hospital of Fujian Medical University
Conditions Rectal Neoplasms
Enrollment 690 participants
Start Date 2025-01-01
Primary Completion 2025-09-01 (estimated)
Study Completion 2025-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-19